RegisterLogin

WEHI-P8

CAT: 0804-HY-172350Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-172350Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
WEHI-P8 is an orally active inhibitor targeting the papain-like protease (PLpro) of coronaviruses. WEHI-P8 againsts SARS-CoV-2 PLpro with an IC50 value of 12 nM. WEHI-P8 has good cellular activity with a EC50 of 298 nM. WEHI-P8 protects mice from SARS-CoV-2 induced long-term symptoms in lung and brain. WEHI-P8 can be used for post-acute sequelae of COVID-19 study[1].
UNSPSC
12352005
Target
SARS-CoV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
CCO/N=C([C@@H]1CCCN(C1)[C@H]2CC[C@H](CC2)O)/C3=CC4=C(C=C(C=C4)OC)C=C3
Molecular Formula
C25H34N2O3
Molecular Weight
410.55
References & Citations
[1]M Bader S, et al. A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID. Nat Commun. 2025 Apr 3;16 (1) :2900.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-18937-01WEHI-345
HY-128777-01WEHI-9625
HY-175362WEHI-326
HY-15607-01WEHI-539
HY-172262-01WEHI-3773
HY-147740WEHI-150
HY-100112-01WEHI-345 analog
HY-15607A-01WEHI-539 hydrochloride
HY-141453Desmethyl-WEHI-345 analog
HY-P0111-01Z-WEHD-FMK

Alternative Products

CatalogName
T207007-01WEHI-P8
ABC-TC1283WEHI 3BD
ABL-TC0742WEHI-3b
T62582-01WEHI-150
526614WEHI-345
T13338-01WEHI-9625
MBS5767854WEHI-539
ABC-TC1285WEHI-164
ARC1006WEHI-231
T206161-01WEHI-3773

Popular Products